Procept Biorobotics Corp

詳細情報 Procept Biorobotics Corp 企業名

PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.

企業情報

企業コードPRCT

会社名Procept Biorobotics Corp

上場日Sep 15, 2021

設立日2021

最高経営責任者「CEO」Dr. Reza Zadno, Ph.D.

従業員数756

証券種類Ordinary Share

決算期末Sep 15

本社所在地150 Baytech Drive

都市SAN JOSE

証券取引所NASDAQ Global Market Consolidated

国United States of America

郵便番号95134

電話番号16502329832

ウェブサイトhttps://www.procept-biorobotics.com/

企業コードPRCT

上場日Sep 15, 2021

設立日2021

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Frederic H. (Fred) Moll, M.D.

Independent Director

843.16K

+0.18%

Mr. Taylor C. Harris

Independent Director

134.25K

+1.16%

Mr. Kevin Waters

Executive Vice President, Chief Financial Officer

66.61K

-6.22%

Dr. Reza Zadno, Ph.D.

President, Chief Executive Officer, Director

65.97K

+26.35%

Mr. Hisham Shiblaq

Executive Vice President, Chief Commercial Officer

18.05K

--

Ms. Mary Garrett

Independent Director

14.38K

+11.97%

Ms. Elisabeth Little

Independent Director

11.02K

--

Mr. Larry L. Wood

Independent Director

5.97K

+34.72%

Thomas M. Prescott

Independent Chairman of the Board

3.90K

+65.22%

Ms. Alaleh Azarkhish Nouri

Executive Vice President, Chief Legal Officer, Corporate Secretary

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Frederic H. (Fred) Moll, M.D.

Independent Director

843.16K

+0.18%

Mr. Taylor C. Harris

Independent Director

134.25K

+1.16%

Mr. Kevin Waters

Executive Vice President, Chief Financial Officer

66.61K

-6.22%

Dr. Reza Zadno, Ph.D.

President, Chief Executive Officer, Director

65.97K

+26.35%

Mr. Hisham Shiblaq

Executive Vice President, Chief Commercial Officer

18.05K

--

Ms. Mary Garrett

Independent Director

14.38K

+11.97%

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Hand pieces and other consumables

42.49M

61.43%

System sales and rentals

22.54M

32.59%

Service

4.13M

5.98%

地域別USD

会社名

収益

比率

United States

60.29M

87.18%

Outside United States

8.87M

12.82%

事業別

地域別

事業別USD

会社名

収益

比率

Hand pieces and other consumables

42.49M

61.43%

System sales and rentals

22.54M

32.59%

Service

4.13M

5.98%

株主

更新時刻: Sun, Jun 8

株主統計

種類

株主統計

比率

Fidelity Management & Research Company LLC

14.67%

The Vanguard Group, Inc.

9.25%

BlackRock Institutional Trust Company, N.A.

6.24%

AllianceBernstein L.P.

3.87%

T. Rowe Price Investment Management, Inc.

2.56%

Other

63.41%

株主統計

比率

Fidelity Management & Research Company LLC

14.67%

The Vanguard Group, Inc.

9.25%

BlackRock Institutional Trust Company, N.A.

6.24%

AllianceBernstein L.P.

3.87%

T. Rowe Price Investment Management, Inc.

2.56%

Other

63.41%

種類

株主統計

比率

Investment Advisor

45.36%

Investment Advisor/Hedge Fund

34.67%

Hedge Fund

7.57%

Individual Investor

4.25%

Research Firm

3.31%

Bank and Trust

1.10%

Pension Fund

0.73%

Venture Capital

0.66%

Family Office

0.08%

Other

2.26%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

528

53.99M

97.59%

-2.22M

2025Q1

539

53.99M

97.68%

-2.82M

2024Q4

499

53.70M

99.42%

+875.53K

2024Q3

449

49.13M

94.16%

-1.41M

2024Q2

393

47.17M

91.61%

-2.29M

2024Q1

345

48.36M

95.04%

-4.45M

2023Q4

326

47.80M

94.81%

-4.63M

2023Q3

322

46.77M

93.30%

+2.15M

2023Q2

298

38.23M

84.44%

-1.74M

2023Q1

275

35.37M

78.88%

-3.41M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Fidelity Management & Research Company LLC

8.12M

14.67%

+55.63K

+0.69%

Mar 31, 2025

The Vanguard Group, Inc.

5.12M

9.25%

-14.09K

-0.27%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

3.45M

6.24%

-11.08K

-0.32%

Mar 31, 2025

AllianceBernstein L.P.

2.14M

3.87%

+391.21K

+22.32%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

1.42M

2.56%

+429.46K

+43.56%

Mar 31, 2025

State Street Global Advisors (US)

1.19M

2.15%

-1.44K

-0.12%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.18M

2.14%

+19.63K

+1.69%

Mar 31, 2025

Loomis, Sayles & Company, L.P.

1.18M

2.14%

-25.76K

-2.13%

Mar 31, 2025

T. Rowe Price Associates, Inc.

1.01M

1.83%

+334.20K

+49.20%

Mar 31, 2025

Wellington Management Company, LLP

962.24K

1.74%

-528.72K

-35.46%

Mar 31, 2025

詳細を見る

58.930USD

Procept Biorobotics Corp

58.930

概要

企業名

金融